secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lipocine Inc. (LPCN)
CIK:        0001535955
Form:       8-K
Filed at:   2022-01-21T23:59:59+00:00
Accession:  0001493152-22-001941
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lipocine CFO Morgan Brown resigns effective Jan 31; Krista Fogarty appointed Principal Accounting Officer
--------------------------------------------------------------------------------

- Morgan Brown resigns as EVP and CFO, effective Jan 31, 2022; no disagreement with company.
- CEO Mahesh Patel will serve as interim Principal Financial Officer until successor is appointed.
- Krista Fogarty, Corporate Controller, appointed Principal Accounting Officer effective Jan 19, 2022.
- Fogarty has prior CFO and controller experience at biotech and pharma companies including NPS Pharmaceuticals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/0001493152-22-001941-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-001941

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer